Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: Mechanism involved

doi:10.3748/wjg.v11.i14.2101

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2648)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

279

HTML

1966

Figures (1-5)

222

Tables (1-3)

181

Sum=2648

Apr 14, 2005 (publication date) through Jul 3, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 14, 2005; 11(14): 2101-2108
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2101

Full Size Figure Download Figure

Figure 4 Transmission electron microscopy of ILN A: Metastatic Pc-3 cells (arrow) in lymphatic tissue of control group (4×10³); B: After ³²P colloids irradiation apoptotic cells (arrow) in the connective tissue and endothelium of lymphatic sinuses (2. 5×10³); C: Denatured tumor cells (arrow) after medication (5×10³×1.2); D: ILN under light microscope: lymphatic tissue recovered to normal 4 wk after medication (HE ×400).

Citation: Liu L, Feng GS, Gao H, Tong GS, Wang Y, Gao W, Huang Y, Li C. Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: Mechanism involved. World J Gastroenterol 2005; 11(14): 2101-2108
URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2101.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2101